Wim Schepens

622 total citations
10 papers, 339 citations indexed

About

Wim Schepens is a scholar working on Organic Chemistry, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Wim Schepens has authored 10 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 5 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Wim Schepens's work include Chemical Synthesis and Analysis (4 papers), Click Chemistry and Applications (3 papers) and Vitamin D Research Studies (3 papers). Wim Schepens is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Click Chemistry and Applications (3 papers) and Vitamin D Research Studies (3 papers). Wim Schepens collaborates with scholars based in Belgium, Netherlands and United States. Wim Schepens's co-authors include Bert U. W. Maes, Steven Ballet, Herman van Vlijmen, Rebecca J. M. Goss, Christophe Buyck, Jaap Goudsmit, Ian A. Wilson, Chan Tang, Robert H. Friesen and Bart Kesteleyn and has published in prestigious journals such as Science, Organic Letters and The Journal of Steroid Biochemistry and Molecular Biology.

In The Last Decade

Wim Schepens

9 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wim Schepens Belgium 8 179 176 59 44 31 10 339
Daan van der Es Netherlands 11 237 1.3× 148 0.8× 26 0.4× 32 0.7× 26 0.8× 26 349
Magdolna Csávás Hungary 15 282 1.6× 376 2.1× 20 0.3× 18 0.4× 31 1.0× 37 504
Dazhong Ding China 8 172 1.0× 216 1.2× 89 1.5× 30 0.7× 27 0.9× 9 403
J. Castro-López Spain 10 302 1.7× 194 1.1× 21 0.4× 114 2.6× 23 0.7× 17 396
Andrea Bistrović United Kingdom 12 139 0.8× 227 1.3× 22 0.4× 10 0.2× 23 0.7× 20 374
Dawn E. Verdugo United States 10 198 1.1× 143 0.8× 48 0.8× 20 0.5× 54 1.7× 11 387
Ravikumar Jimmidi India 9 165 0.9× 91 0.5× 25 0.4× 18 0.4× 24 0.8× 12 276
Steven Pratt United Kingdom 12 244 1.4× 163 0.9× 60 1.0× 16 0.4× 50 1.6× 15 473
Nilkanth G. Aher India 7 174 1.0× 435 2.5× 23 0.4× 18 0.4× 59 1.9× 9 519
Lawrence D. Harris New Zealand 11 137 0.8× 150 0.9× 28 0.5× 5 0.1× 75 2.4× 31 373

Countries citing papers authored by Wim Schepens

Since Specialization
Citations

This map shows the geographic impact of Wim Schepens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wim Schepens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wim Schepens more than expected).

Fields of papers citing papers by Wim Schepens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wim Schepens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wim Schepens. The network helps show where Wim Schepens may publish in the future.

Co-authorship network of co-authors of Wim Schepens

This figure shows the co-authorship network connecting the top 25 collaborators of Wim Schepens. A scholar is included among the top collaborators of Wim Schepens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wim Schepens. Wim Schepens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kadam, Rameshwar U., Jarek Juraszek, Boerries Brandenburg, et al.. (2025). VHH antibody loop guides design of a synthetic macrocyclic peptide that potently blocks influenza virus membrane fusion. PubMed. 3(1). 83–83.
2.
Schepens, Wim, Herman van Vlijmen, Nga N. Chung, et al.. (2018). Chemical space screening around Phe3 in opioid peptides: Modulating µ versus δ agonism by Suzuki-Miyaura cross-couplings. Bioorganic & Medicinal Chemistry Letters. 28(13). 2320–2323. 4 indexed citations
3.
Kadam, Rameshwar U., Jarek Juraszek, Boerries Brandenburg, et al.. (2017). Potent peptidic fusion inhibitors of influenza virus. Science. 358(6362). 496–502. 120 indexed citations
4.
Schepens, Wim, et al.. (2017). The Suzuki–Miyaura Cross-Coupling as a Versatile Tool for Peptide Diversification and Cyclization. Catalysts. 7(3). 74–74. 68 indexed citations
5.
Goss, Rebecca J. M., et al.. (2015). Suzuki–Miyaura Diversification of Amino Acids and Dipeptides in Aqueous Media. ChemCatChem. 7(14). 2055–2070. 32 indexed citations
6.
Gkotsi, Danai S., et al.. (2014). The First One-Pot Synthesis of l-7-Iodotryptophan from 7-Iodoindole and Serine, and an Improved Synthesis of Other l-7-Halotryptophans. Organic Letters. 16(10). 2622–2625. 54 indexed citations
7.
Jonckers, Tim H. M., M.C. Rouan, Wim Schepens, et al.. (2012). Benzoxazole and benzothiazole amides as novel pharmacokinetic enhancers of HIV protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(15). 4998–5002. 28 indexed citations
8.
Clercq, Pierre J. De, Wim Schepens, Dirk Van Haver, et al.. (2007). The development of CD-ring modified analogs of 1α,25-dihydroxyvitamin D. The Journal of Steroid Biochemistry and Molecular Biology. 103(3-5). 206–212. 8 indexed citations
9.
Schepens, Wim, Dirk Van Haver, M. Vandewalle, et al.. (2006). Synthesis of Spiro[4.5]decane CF-Ring Analogues of 1α,25-Dihydroxyvitamin D3. Organic Letters. 8(19). 4247–4250. 15 indexed citations
10.
Schepens, Wim, Dirk Van Haver, M. Vandewalle, et al.. (2004). Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1α,25-dihydroxyvitamin D3: spiro[5.5]undecane CF-ring analogues. Bioorganic & Medicinal Chemistry Letters. 14(15). 3889–3892. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026